Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl
Open Access
- 22 November 2010
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (50) , 21665-21670
Abstract
Gaucher disease (GD), the most common lysosomal storage disorder of humans, is caused by mutations in the gene coding for the enzyme glucocerebrosidase (GCase). Clinical manifestations vary among patients with the three types of GD, and phenotypic heterogeneity occurs even among patients with identical mutations. To gain insight into why phenotypic heterogeneity occurs in GD, we investigated mechanisms underlying the net loss of GCase catalytic activity in cultured skin fibroblasts derived from patients with the three types of GD. The findings indicate that the loss of catalytic activity of GCase correlates with its quantitative reduction, rather than a decrease in functional capacity of mutant enzyme. Use of a proteasome inhibitor, lactacystin, resulted in increased expression of GCase, suggesting a mechanism of protein degradation in GD. Furthermore, reduced binding of GCase to TCP1 ring complex (TRiC), a regulator of correct protein folding, may result in defective maturation of nascent GCase in GD cells. Additionally, increased interaction between GCase and c-Cbl, an E3 ubiquitin ligase, may be involved in the degradation and loss of GCase in GD. The findings suggest that specific molecular mediators involved in GCase maturation and degradation could be responsible for phenotypic variation among patients with the same genotypes and that these mediators could be therapeutically targeted to increase GCase activity in patients with GD.Keywords
This publication has 32 references indexed in Scilit:
- Synergistic Signals for Natural Cytotoxicity Are Required to Overcome Inhibition by c-Cbl Ubiquitin LigaseImmunity, 2010
- Disease severity in sibling pairs with type 1 Gaucher diseaseJournal of Inherited Metabolic Disease, 2010
- RING Domain E3 Ubiquitin LigasesAnnual Review of Biochemistry, 2009
- The role of molecular chaperones in human misfolding diseasesFEBS Letters, 2009
- Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologiesNature Structural & Molecular Biology, 2008
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding DiseasesCell, 2008
- Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domainBiochemical and Biophysical Research Communications, 2005
- The Cbl interactome and its functionsNature Reviews Molecular Cell Biology, 2005
- Analysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher DiseaseThe American Journal of Human Genetics, 2000
- Structure of the Substrate Binding Domain of the Thermosome, an Archaeal Group II ChaperoninCell, 1997